Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
J Urol. 2021 Feb;205(2):483-490. doi: 10.1097/JU.0000000000001329. Epub 2020 Aug 17.
Radical cystectomy/urinary diversion is a high risk procedure. Intraoperative stents are commonly utilized to decrease ureteroenteric anastomosis related complications. Institutionally some surgeons routinely use intraoperative stents while others do not, providing an opportunity to compare complication differences.
We queried a prospective database of 283 patients enrolled in a randomized controlled trial evaluating 30-day perioperative complications with goal directed fluid therapy following open radical cystectomy/urinary diversion between 2014 and 2018. Ureteroenteric anastomosis specific complications (ureteral obstruction, urinary leak, urinary infections/sepsis and intra-abdominal abscess) were compared between groups (intraoperative stent vs nonintraoperative stent group) using Fisher exact test and quantified using logistic regression.
The nonintraoperative stent group (77 of 283 patients, 27%) was older (median 72 vs 69 years) and was more likely to receive neoadjuvant chemotherapy (53% vs 40%), have baseline renal insufficiency (43% vs 30%) and undergo an ileal conduit (92% vs 53%). However, despite higher comorbidity, the nonintraoperative stent group had a significantly lower rate of ureteroenteric anastomosis complications (14% vs 32%, p=0.004). Since continent diversions may be associated with higher complications, the nonintraoperative stent group with ileal conduit was also compared to intraoperative stent cohorts with ileal conduit, and ureteroenteric anastomosis complications remained lower in the nonintraoperative stent group (14% vs 28%, p=0.043). Multivariable logistic regression showed significantly increased odds of urinary complications with intraoperative stent use (OR 3.55, 95% CI 2.93-4.31; p <0.0001). Importantly there was no obstruction and only 1 leak (1.3%) in the nonintraoperative stent group.
Contrary to conventional belief, we found intraoperative stent use in radical cystectomy/urinary diversion was associated with significantly higher infectious complications and urgent care visits, and significantly increased the odds of 30-day ureteroenteric anastomosis associated complications.
根治性膀胱切除术/尿流改道术是一种高风险的手术。术中支架通常用于降低输尿管-肠吻合口相关并发症。一些机构的外科医生常规使用术中支架,而另一些则不使用,这为比较并发症差异提供了机会。
我们查询了 2014 年至 2018 年期间一项旨在评估 30 天围手术期并发症的前瞻性数据库,该数据库纳入了 283 例接受开放性根治性膀胱切除术/尿流改道术的随机对照试验患者。使用 Fisher 精确检验比较输尿管-肠吻合口特定并发症(输尿管梗阻、尿漏、尿路感染/败血症和腹腔脓肿)在两组之间的差异(术中支架组与非术中支架组),并使用逻辑回归进行量化。
非术中支架组(283 例患者中的 77 例,27%)年龄较大(中位数 72 岁比 69 岁),更有可能接受新辅助化疗(53%比 40%),基线肾功能不全(43%比 30%)和接受回肠代膀胱(92%比 53%)。然而,尽管合并症较高,但非术中支架组的输尿管-肠吻合口并发症发生率明显较低(14%比 32%,p=0.004)。由于可控性膀胱可能与更高的并发症相关,因此还将非术中支架组与回肠代膀胱的术中支架队列进行了比较,非术中支架组的输尿管-肠吻合口并发症仍然较低(14%比 28%,p=0.043)。多变量逻辑回归显示,术中支架使用与尿系并发症的发生几率显著增加相关(OR 3.55,95%CI 2.93-4.31;p<0.0001)。重要的是,非术中支架组无梗阻,仅有 1 例漏尿(1.3%)。
与传统观念相反,我们发现根治性膀胱切除术/尿流改道术中使用术中支架与显著更高的感染性并发症和紧急护理就诊相关,并且显著增加了 30 天输尿管-肠吻合口相关并发症的发生几率。